ISNS is recognized worldwide for its contributions to the detection of neonatal conditions and the prevention of their adverse outcomes through excellence in neonatal screening.
To enhance the quality of neonatal screening and medical services through dissemination of information, guidelines and best practices that benefit all family members and their babies by helping to ensure protection of babies from life-quality threatening conditions, such as phenylketonuria, congenital hypothyroidism, severe combined immunodeficiency, cystic fibrosis, hemoglobinopathies and many others.
Welcome to the website of the International Society for Neonatal Screening (ISNS).
This society is aiming to advance screening for neonatal and infant sicknesses and disorders, worldwide.
ISNS has around 470 members in more than 70 different countries. Most members have a professional (para)medical background but a few are involved in parents’ or patients’ organisations.
For more information about ISNS visit the ISNS-Info section (see above).
ISNS welcomes new members who have demonstrated an active interest in neonatal screening.
The location of members worldwide as of Jan. 1, 2017, is shown in the picture on the right. Countries/states with at least one member are shown in blue, others in grey.
How do I become a member?
Please read this and subsequently click on the button “Member subscribe”
Why should I join as a member?
As a member you are entitled to see the privileged pages containing specific news items, a monthly neonatal screening literature service and a discount to ISNS-related conferences. Under certain conditions you may apply for travel grants to such conferences. Having access to the on line membership directory you have easier access to other members sharing specific interests.
Resource on the State of the Art of Rare Disease Activities in Europe
UK NSC review calls for trial period to...Read more
Italy recently adopted a law for mandated national screening for 40 congenital and metabolic conditions....Read more